Top 10 Books about Stock Investing to read in 2018. Read more.

IMUC - ImmunoCellular Therapeutics Ltd

Industry: Biotechnology Sector: Healthcare

IMUC - ImmunoCellular Therapeutics Ltd

Industry: Biotechnology Sector: Healthcare

Fri 15'th Jun 2018

PERIOD 2018-03-16 - 2018-06-15
CHANGE 5.92%
PRICE $0.27





Request Prediction

ImmunoCellular Therapeutics Ltd Stock Analysis

Technical stock analysis for Fri 15'th Jun 2018

Buy candidate since 2018-06-14 Gain 5.92%

ImmunoCellular Therapeutics Ltd gained 5.92% in the last trading day, rising from $0.25 to $0.27 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a 8% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 24 874 more shares were traded than the day before. In total, 261 632 shares bought and sold for approximately $0.00.

Shorts 5.48% ( 2018-05-31 )
Cash n/a
Loans n/a
Beta 0.51
ROA -147.53


ImmunoCellular Therapeutics Ltd lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.21% during the next 3 months and, with 90% probability hold a price between $0.24 and $0.30 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. ImmunoCellular Therapeutics Ltd holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $0.26 and $0.26. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday June 13, 2018, which indicates further gains until a new top pivot has been found. ImmunoCellular Therapeutics Ltd has rising volume and follows the last lift in the price. This considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 48 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

ImmunoCellular Therapeutics Ltd finds support from accumulated volume at $0.27.

Support: $0.27 Price: $0.27 Resistance: $0.27


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 8.00%. For the last week, the stock has had a daily average volatility of 6.14%.

Our recommended stoploss: $0.26 (-4.55%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Trade IMUC CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features